Educational Intervention for Colorectal Cancer Screening
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if educational sessions, known as the Educational Intervention, can boost knowledge and screening rates for colorectal cancer. Participants will engage in activities such as walking through an inflatable colon or watching a culturally tailored PowerPoint presentation. The goal is to increase awareness of colorectal cancer and encourage more frequent screenings. Residents of Franklin County or Appalachia Ohio are well-suited for this trial. As an unphased trial, this study provides participants the chance to contribute to important research that could improve community health awareness and screening practices.
What prior data suggests that this educational intervention is safe?
Research has shown that educational activities, such as those in this trial, are generally safe. These activities often use tools like videos, flip books, or presentations to teach health topics. They increase awareness and understanding without involving medical procedures or drugs. No reports of negative effects have emerged from participating in these educational activities. Therefore, joining a trial with an educational activity is considered low-risk.12345
Why are researchers excited about this trial?
Researchers are excited about the educational intervention for colorectal cancer screening because it offers a unique approach to increasing awareness and screening rates. Unlike traditional methods, this intervention uses an interactive inflatable colon exhibit, culturally and linguistically tailored presentations, and engaging materials like flip books. These features aim to make the information more relatable and accessible, especially for diverse communities such as Black/African Americans, Appalachians, and Hispanics/Latinos. By making education more interactive and culturally relevant, this approach could significantly improve participation and early detection rates, leading to better outcomes.
What evidence suggests that this educational intervention is effective for improving colorectal cancer screening rates?
Research has shown that educational programs can increase colorectal cancer screening rates. In this trial, participants will receive an educational intervention featuring interactive displays and personalized presentations. For instance, patient navigation, which guides patients through the healthcare system, has proven effective in boosting screening rates. One study found that patient navigation increased screening rates by 7.3% compared to regular care. Another study demonstrated that patients involved in educational activities were significantly more likely to complete colonoscopy screenings, achieving a 96.2% completion rate, compared to those receiving regular care. These findings suggest that educational tools, like those used in this trial, play a crucial role in raising awareness and encouraging more people to undergo colorectal cancer screening.14678
Who Is on the Research Team?
Electra Paskett, PhD
Principal Investigator
Ohio State University Comprehensive Cancer Center
Are You a Good Fit for This Trial?
This trial is for individuals from Franklin County or Appalachia Ohio. It's designed to see if certain educational tools can increase understanding and screening rates for colorectal cancer.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Educational Intervention
Participants attend educational sessions comprising of an inflatable colon interactive exhibit, PowerPoint presentation, and flip books/flip charts to improve knowledge and screening rates for colorectal cancer.
Follow-up
Participants are monitored for changes in knowledge, intentions, and screening behaviors related to colorectal cancer.
What Are the Treatments Tested in This Trial?
Interventions
- Educational Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University Comprehensive Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator